Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Enovis Corporation (ENOV : NYSE)
 
 • Company Description   
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

Number of Employees: 7,367

 
 • Price / Volume Information   
Yesterday's Closing Price: $33.65 Daily Weekly Monthly
20 Day Moving Average: 1,507,239 shares
Shares Outstanding: 57.12 (millions)
Market Capitalization: $1,922.19 (millions)
Beta: 1.70
52 Week High: $49.83
52 Week Low: $28.83
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.85% 1.15%
12 Week 5.12% -10.21%
Year To Date -23.31% -28.17%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2711 Centerville Road Suite 400
-
Wilmington,DE 19808
USA
ph: 302-252-9160
fax: 301-323-9001
investorrelations@enovis.com http://www.enovis.com
 
 • General Corporate Information   
Officers
Matthew L. Trerotola - Chief Executive Officer and Chairman
Phillip B. Berry - Senior Vice President and Chief Financial Officer
Daniel A. Pryor - Executive Vice President
Bradley J. Tandy - Senior Vice President
Patricia Lang - Senior Vice President

Peer Information
Enovis Corporation (HLIS)
Enovis Corporation (AZTA)
Enovis Corporation (APYI)
Enovis Corporation (RNVA)
Enovis Corporation (HMSY)
Enovis Corporation (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 194014502
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
Share - Related Items
Shares Outstanding: 57.12
Most Recent Split Date: 4.00 (0.33:1)
Beta: 1.70
Market Capitalization: $1,922.19 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.66 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $3.04 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 11.07
Trailing 12 Months: 10.72
PEG Ratio: -
Price Ratios
Price/Book: 0.73
Price/Cash Flow: 1.75
Price / Sales: 0.89
EPS Growth
vs. Year Ago Period: 62.00%
vs. Previous Quarter: -17.35%
Sales Growth
vs. Year Ago Period: 8.25%
vs. Previous Quarter: -0.38%
ROE
06/30/25 - -
03/31/25 - 5.99
12/31/24 - 5.06
ROA
06/30/25 - -
03/31/25 - 3.44
12/31/24 - 2.98
Current Ratio
06/30/25 - -
03/31/25 - 2.55
12/31/24 - 2.17
Quick Ratio
06/30/25 - -
03/31/25 - 1.32
12/31/24 - 1.13
Operating Margin
06/30/25 - -
03/31/25 - 8.23
12/31/24 - 7.50
Net Margin
06/30/25 - -
03/31/25 - -37.65
12/31/24 - -39.17
Pre-Tax Margin
06/30/25 - -
03/31/25 - -37.25
12/31/24 - -39.04
Book Value
06/30/25 - -
03/31/25 - 45.88
12/31/24 - 45.10
Inventory Turnover
06/30/25 - -
03/31/25 - 1.59
12/31/24 - 1.57
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.52
12/31/24 - 0.51
Debt-to-Capital
06/30/25 - -
03/31/25 - 34.29
12/31/24 - 33.80
 

Powered by Zacks Investment Research ©